相关实验视频

Updated: Jul 8, 2025

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
07:00

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas

Published on: February 28, 2019

5.9K

在SMARCB1 (INI-1) 缺陷鼻癌中的免疫疗法:两个病例报告

Lu Zhang1, Ai-Xin Gao2, Yu-Lu He3

  • 1Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong Province, China.

World journal of clinical cases
|December 11, 2023
PubMed
概括

缺少SMARCB1/INI-1的鼻癌 (SDSC) 很少见,并且难以诊断. 免疫疗法显示出作为SDSC的新型治疗选择的希望,补充传统疗法.

关键词:
案例报告案例报告有缺少基因的基因.在INI-1中,INI-1是指INI-1.免疫治疗是一种免疫疗法.在SMARCB1中,鼻癌 (sinonasal carcinoma) 是一种鼻癌.手术 手术 手术 术 术

更多相关视频

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.5K
Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model09:57

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model

Published on: June 4, 2017

12.3K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529